Cartesian Therapeutics GAAP EPS of -$1.66 misses by $1.64, revenue of $26M beats by $15.4M
Cartesian Therapeutics GAAP EPS of -$1.66 misses by $1.64, revenue of $26M beats by $15.4M
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
-
SAB Biotherapeutics GAAP EPS of -$7.64 misses by $3.43, revenue of $2.24M beats by $1.12M
SeekingAlpha
-
Zevra Therapeutics GAAP EPS of -$1.30 misses by $0.12, revenue of $27.46M beats by $1.48M
SeekingAlpha
-
P3 Health Partners GAAP EPS of -$0.22 misses by $0.11, revenue of $346.9M beats by $44.17M
SeekingAlpha
-
Semtech Non-GAAP EPS of -$0.06 misses by $0.02, revenue of $192.95M beats by $2.23M
SeekingAlpha
Advertisement
More coverage
-
Draganfly GAAP EPS of -$0.56 misses by $0.11, revenue of $6.55M beats by $0.01M
SeekingAlpha
-
Intrusion GAAP EPS of -$0.09 beats by $2.11, revenue of $1.4M misses by $0.24M
SeekingAlpha
-
nCino Non-GAAP EPS of $0.21 beats by $0.09, revenue of $123.7M misses by $0.55M
SeekingAlpha
-
Stoke Therapeutics GAAP EPS of -$0.60 beats by $0.02, revenue of $2.8M misses by $0.42M
SeekingAlpha